Cell-Nonautonomous Effects of dFOXO/DAF-16 in Aging

Abstract
dfoxo/daf-16 is not required beyond gut/adipose tissue to counteract aging • Neuroendcrine dFOXO extends lifespan independently of dfoxo in other cell types • In contrast, gut/adipose dFOXO requires dfoxo in other tissues to alter metabolism
Funding Information
  • Wellcome Trust
  • International Max Planck Research School for Advanced Methods in Process and Systems Engineering
  • National Institutes of Health (P40 OD010440)